Transplanted human bone marrow mesenchymal stem cells seeded onto peptide hydrogel decrease alveolar bone loss

BioResearch Open Access

Volumn 1, Issue 5, 2012, Pages 215-221

  Tcacencu, Ion ^a   Karlström, Erik ^a   Cedervall, Jessica ^b   Wendel, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Bone repair; Inflammation; Osteoclast; Puramatrix

Indexed keywords

CYCLOSPORIN A;

ALVEOLAR BONE LOSS; ALVEOLAR BONE VOLUME DENSITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MARROW TRANSPLANTATION; BONE MASS; CONTROLLED STUDY; HISTOPATHOLOGY; HYDROGEL; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MORPHOMETRICS; NONHUMAN; OSTEOCLAST; PERIODONTIUM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; TISSUE REACTION; WOUND HEALING;

EID: 84890564416     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2012.0239     Document Type: Article

References (31)

1. Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontol 2000. 2006;40:11-28.
2. Papapanou PN, Tonetti MS. Diagnosis and epidemiology of periodontal osseous lesions. Periodontol 2000. 2000;22:8-21.
3. Wang HL, Greenwell H, Fiorellini J, et al. Periodontal regeneration. J Periodontol. 2005;76:1601-1622.
4. Zohar R, Tenenbaum HC. How predictable are periodontal regenerative procedures? J Can Dent Assoc. 2005;71:675-680.
5. Carnevale G, Kaldahl WB. Osseous resective surgery. Periodontol 2000. 2000;22:59-87.
6. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25:2739-2749.
7. Maggini J, Mirkin G, Bognanni I, et al. Mouse bone marrowderived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010;5:e9252.
8. Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34 + -derived and monocyte-derived dendritic cells. J Immunol. 2006;177:2080-2087.
9. Srouji S, Kizhner T, Livne E. 3D scaffolds for bone marrow stem cell support in bone repair. Regen Med. 2006;1: 519-528.
10. Semino CE. Self-assembling peptides: From bio-inspired materials to bone regeneration. J Dent Res. 2008;87:606-616.
11. Mankani MH, Kuznetsov SA, Marshall GW, et al. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A. 2008;14:1949-1958.
12. King GN, Hughes FJ. Bone morphogenetic protein-2 stimulates cell recruitment and cementogenesis during early wound healing. J Clin Periodontol. 2001;28: 465-475.
13. Movsowitz C, Epstein S, Fallon M, et al. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology. 1988;123: 2571-2577.
14. Hertegård S, Cedervall J, Svensson B, et al. Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection. Laryngoscope. 2006;116: 1248-1254.
15. Nicklas JA, Buel E. Development of an Alu-based, real-time PCR method for quantitation of human DNA in forensic samples. J Forensic Sci. 2003;48:936-944.
16. Dalle Carbonare L, Valenti MT, Bertoldo F, et al. Bone microarchitecture evaluated by histomorphometry. Micron. 2005; 36:609-616.
17. Vedi S, Compston J. Bone histomorphometry. Methods Mol Med. 2003;80:283-298.
18. Aukhil I. Biology of wound healing. Periodontol 2000. 2000; 22:44-50.
19. Bokhari MA, Akay G, Zhang S, et al. The enhancement of osteoblast growth and differentiation in vitro on a peptide hydrogel-polyHIPE polymer hybrid material. Biomaterials. 2005;26:5198-5208.
20. Misawa H, Kobayashi N, Soto-Gutierrez A, et al. PuraMatrix facilitates bone regeneration in bone defects of calvaria in mice. Cell Transplant. 2006;15:903-910.
21. Kutschka I, Chen IY, Kofidis T, et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation. 2006;114:167-173.
22. Lu D, Mahmood A, Qu C, et al. Collagen scaffolds populated with human marrow stromal cells reduce lesion volume and improve functional outcome after traumatic brain injury. Neurosurgery. 2007;61:596-602.
23. Tour G, Wendel M, Tcacencu I. Bone marrow stromal cells enhance the osteogenic properties of hydroxyapatite scaffolds by modulating the foreign body reaction. J Tissue Eng Regen Med. 2012 Jul 10 [Epub ahead of print]; DOI: 10.1002/term.1574.
24. Keating A. How do mesenchymal stromal cells suppress T cells? Cell Stem Cell. 2008;2:106-108.
25. Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med. 2005;11:76-81.
26. Chambers TJ. Regulation of the differentiation and function of osteoclasts. J Pathol. 2000;192:4-13.
27. Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15:42-49.
28. Evans KE, Fox SW. Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus. BMC Cell Biol. 2007;8:4.
29. Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in prosurvival factors enhance function of infarcted rat hearts. Nat Biotechnol. 2007;25:1015-1024.
30. Pasha Z, Wang Y, Sheikh R, et al. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. 2008; 77:134-142.
31. Castano-Izquierdo H, Alvarez-Barreto J, van den Dolder J, et al. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A. 2007;82:129-138.